PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Prednisolone - Inflammatory bowel disease
PAD Profile : Prednisolone - Inflammatory bowel disease
Keywords :
IBD, chronic bowel disorders, UC, Ulcerative colitis, Crohn's disease
Brand Names Include :
Predfoam
Traffic Light Status
Status 1 of 5.
Status :
Non Formulary
Important
Formulations :
- Foam enema
Important Information :
Budesonide rectal foam is preferred.
Steroid safety considerations
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 5.
Status :
Green
Important
Formulations :
- Tablets
Important Information :
Tablets can be dispersed for immediate administration.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 5.
Status :
Green
Important
Formulations :
- Soluble tablets
Important Information :
Paediatrics only at SASH.
Paediatrics and oncology at ASPH
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 4 of 5.
Status :
Green
Important
Formulations :
- Oral solution
Important Information :
Paediatric doses and NG/NJ tube only
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 5 of 5.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Adalimumab
- Azathioprine
- Infliximab
- Mercaptopurine
- Ciclosporin
- Golimumab
- Vedolizumab
- Allopurinol
- Balsalazide sodium
- Budesonide
- Tofacitinib
- Methotrexate
- Mesalazine (Systemic)
- Filgotinib
- Sulfasalazine
- Upadacitinib
- Risankizumab
- Olsalazine sodium
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
13 March 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN does not recommend Prednisolone foam enemas as a treatment option for patients with active Ulcerative Colitis
Prednisolone foam enemas will be considered BLACK, for new patients, on the traffic light system
People who are currently receiving prednisolone foam enema should have the option to continue therapy from their usual prescriber until they and their clinicians consider it appropriate to stop.
Primary care prescribers should consider switching patients to budesonide rectal foam and for all new patients.
Associated BNF Codes
01. Gastro-Intestinal System
01.05.02. Corticosteroids